Search

everythinglearnresearchcommunity

for

Search:↓

Low testosterone does not prevent prostate cancer in men with type 1 diabetes.

Older women taking spironolactone for hair loss may need yearly potassium checks due to a higher risk of hyperkalemia.

Low level laser therapy works best for hair loss, followed by PRP, finasteride, and minoxidil.

Mild essential fatty acid deficiency can cause health issues and is worsened by low-fat diets.

Low-dose acitretin helps nail psoriasis, stem cells may treat scarring alopecia, Chinese men have lower baldness rates, lateral foldplasty is good for ingrown toenails, hair diameter helps diagnose female baldness, childhood trauma linked to alopecia areata, certain hair-weaving leads to scalp conditions in African American women, and new methods for hair research and understanding hair and sweat gland development were introduced.

Spironolactone is a low-cost, effective, and generally safe treatment for various skin conditions related to hormones.

2007 research improved understanding of prostate cancer risk, diagnosis, and treatment, but also showed the need for personalized treatment and further study on certain therapies' risks.

Finasteride and dutasteride increase sexual dysfunction risk by 1.57 times in male hair loss treatment.

Breast cancer survivors may have a higher risk of falls, tamoxifen could prevent breast cancer and deaths, new guidelines urge caution with prostate cancer therapy, and early balding in men may indicate a higher prostate cancer risk.

5α-reductase inhibitors may prevent prostate cancer but could also raise the risk of more severe cancers.

5-alpha-reductase inhibitors can lower prostate cancer risk but may increase high-grade tumors and cause sexual side effects.

Retinoids can prevent skin cancer in high-risk people but have side effects and require more research on dosing and effectiveness.

New nanocarriers improve skin drug delivery with low toxicity at certain concentrations.

Medicines for enlarged prostate may raise the risk of breast growth and tenderness but not breast cancer.

COVID-19 vaccination does not significantly increase the risk of developing alopecia areata.

In 2007, prostate cancer research improved understanding of risk, diagnosis, and treatment, but also showed heart risks with certain therapies and the need for personalized care.

Inhibiting 5α-reductase can help reduce prostate cancer risk and improve treatment.

The length of the CAG repeat in the androgen receptor gene affects the risk and progression of prostate cancer, BPH, infertility, and undermasculinized genitalia.

Testosterone replacement therapy should be used for men with low testosterone levels and symptoms of hypogonadism, after careful diagnosis and considering individual needs.

JAK inhibitors help hair regrowth in alopecia areata but have a high risk of side effects.

Women with female pattern hair loss may have a higher risk of developing metabolic syndrome.

Dutasteride is effective for treating prostate enlargement and reducing related surgery risk, but is not approved for preventing prostate cancer.

Pregnant women with Systemic Lupus Erythematosus have a higher risk of blood clotting problems.

Severe hair loss (androgenetic alopecia) is linked to higher risk of heart disease (cardiovascular atherosclerosis).

Combination therapy of doxazosin and finasteride safely and effectively reduces benign prostatic hyperplasia progression risk.

The Rotterdam Study aims to understand disease causes in the elderly and has found new risk factors and genetic influences on various conditions.

5 alpha-reductase inhibitors can slightly improve symptoms of enlarged prostate but have a high risk of sexual side effects.

Testosterone therapy in transgender men has both desired effects like increased muscle mass and potential health risks such as higher cardiovascular risk.

Dutasteride more effectively treats hair loss than finasteride, but may increase risk of altered libido.